[FG] van den Anker Johannes

Dao, Kim et al. (2024) ‘Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use’, The Journal of Clinical Pharmacology. 30.05.2024, 64(10), pp. 1295–1303. Available at: https://doi.org/10.1002/jcph.2462.

Blanchard-Rohner, Geraldine et al. (2024) ‘COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children’, Pediatric Infectious Disease Journal, 43(4), pp. 361–364. Available at: https://doi.org/10.1097/inf.0000000000004206.

Grant, R.L. et al. (2024) ‘Comparison of clinical outcomes over time of inpatients with healthcare-associated or community-acquired coronavirus disease 2019 (COVID-19): A multicenter, prospective cohort study’, Infection Control and Hospital Epidemiology, 45(1), pp. 75–81. Available at: https://doi.org/10.1017/ice.2023.143.

Aghlmandi, Soheila, Bielicki, Julia and Bucher, Heiner C. (2024) ‘‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ – Author’s reply’, Clinical Microbiology and Infection [Preprint]. Available at: https://doi.org/10.1016/j.cmi.2024.03.030.

Bender, Rose Grace et al. (2024) ‘Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021’, The Lancet Infectious Diseases, 24, pp. 974–1002. Available at: https://doi.org/10.1016/S1473-3099(24)00176-2.

Bertagnolio, Silvia et al. (2024) ‘WHO global research priorities for antimicrobial resistance in human health’, The Lancet Microbe, 5. Available at: https://doi.org/10.1016/S2666-5247(24)00134-4.

Dangor, Ziyaad et al. (2024) ‘Vaccine value profile for Klebsiella pneumoniae’, Vaccine [Preprint]. Available at: https://doi.org/10.1016/j.vaccine.2024.02.072.

Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin’, Swiss Medical Weekly, 154. Available at: https://doi.org/10.57187/s.3632.

Kakaraskoska Boceska, Biljana et al. (2024) ‘Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries’, Nature Communications, 15. Available at: https://doi.org/10.1038/s41467-024-48296-z.

Meyer Sauteur, Patrick M. et al. (2024) ‘A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study’, Trials, 25. Available at: https://doi.org/10.1186/s13063-024-08438-6.

Minotti, C., Aghlmandi, S. and Bielicki, J.A. (2024) ‘Electronic hand hygiene monitoring tools for implementation of optimal hand sanitizing adherence in neonatal intensive care’, Journal of Hospital Infection, 147, pp. 213–215. Available at: https://doi.org/10.1016/j.jhin.2024.02.018.

Operations, Clinical et al. (2024) ‘Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial’, BMJ Open, 14. Available at: https://doi.org/10.1136/bmjopen-2023-076338.

Schlaeppi, Chloé, Minotti, Chiara and Bielicki, Julia Anna (2024) ‘Infection Control in the NICU: The Roles of Surveillance Cultures’, Pediatric Infectious Disease Journal, 43, pp. E175–E177. Available at: https://doi.org/10.1097/inf.0000000000004293.

Schöbi, Nina et al. (2024) ‘Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARSCoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland’, BMJ Open, 14(4), p. e078137. Available at: https://doi.org/10.1136/bmjopen-2023-078137.

Turner, Rebecca M. et al. (2024) ‘Determining sample size in a personalized randomized controlled (PRACTical) trial’, Statistics in Medicine, 43, pp. 4098–4112. Available at: https://doi.org/10.1002/sim.10168.

Neuner, E.A. et al. (2023) ‘Mixed methods evaluation of handshake antimicrobial stewardship on adult inpatient medicine floors’, Antimicrobial Stewardship and Healthcare Epidemiology, 3(1). Available at: https://doi.org/10.1017/ash.2023.465.

Guillamet, M.C.V. et al. (2023) ‘Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock’, International Journal of Antimicrobial Agents, 62(4), p. 106913. Available at: https://doi.org/10.1016/j.ijantimicag.2023.106913.

Ehlers, Lisa et al. (2023) ‘Treat-to-target strategies for the management of familial Mediterranean Fever in children’, Pediatric Rheumatology, 21(1). Available at: https://doi.org/10.1186/s12969-023-00875-y.

Atkinson, A. et al. (2023) ‘Impact of the Severe acute respiratory syndrome coronavirus 2 pandemic on mortality associated with healthcare-associated infections’, Antimicrobial Stewardship and Healthcare Epidemiology, 3(1). Available at: https://doi.org/10.1017/ash.2023.409.

Satirer, Özlem et al. (2023) ‘Cryopyrin-assoziierte periodische Syndrome’, Arthritis und Rheuma, 43(04), pp. 264–274. Available at: https://doi.org/10.1055/a-2114-0449.

Pfeiffer Y et al. (2023) ‘Preventing Surgical Site Infections: Are Safety Climate Level and Its Strength Associated With Self-reported Commitment To, Subjective Norms Toward, and Knowledge About Preventive Measures?’, Journal of Patient Safety, 19(4), pp. 264–270. Available at: https://doi.org/10.1097/PTS.0000000000001111.

Damonti L et al. (2023) ‘Influence of environmental temperature and heatwaves on surgical site infection after hip and knee arthroplasty: a nationwide study’, Journal of Hospital Infection, 135, pp. 125–131. Available at: https://doi.org/10.1016/j.jhin.2023.03.014.

Weber, A.N.R. et al. (2023) ‘Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply’, Rheumatology (United Kingdom), 62(5), pp. E168–E169. Available at: https://doi.org/10.1093/rheumatology/keac718.

Pfeiffer Y et al. (2023) ‘Are cross-sectional safety climate survey results in operating room staff associated with the surgical site infection rates in Swiss hospitals?’, BMJ Open, 13(4), p. e066514. Available at: https://doi.org/10.1136/bmjopen-2022-066514.

Anna Hachfeld et al. (2023) ‘Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?’, Journal of Acquired Immune Deficiency Syndromes, 92(5), pp. 399–404. Available at: https://doi.org/10.1097/qai.0000000000003158.

Hachfeld Anna et al. (2023) ‘Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?’, Journal of Acquired Immune Deficiency Syndromes, 92(5), pp. 399–404. Available at: https://doi.org/10.1097/QAI.0000000000003158.

Béguelin C et al. (2023) ‘Hepatitis delta infection among persons living with HIV in Europe’, Liver International, 43(4), pp. 819–828. Available at: https://doi.org/10.1111/liv.15519.

D’Incau S et al. (2023) ‘Bacterial species and antimicrobial resistance differ between catheter and non-catheter-associated urinary tract infections: Data from a national surveillance network’, Antimicrobial Stewardship and Healthcare Epidemiology, 3(1), p. e55. Available at: https://doi.org/10.1017/ash.2022.340.

Atkinson A et al. (2023) ‘Extending outbreak investigation with machine learning and graph theory: Benefits of new tools with application to a nosocomial outbreak of a multidrug-resistant organism’, Infection Control and Hospital Epidemiology, 44(2), pp. 246–252. Available at: https://doi.org/10.1017/ice.2022.66.

Wildenthal JA et al. (2023) ‘Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs’, Clinical Infectious Diseases, 76(3), pp. 487–496. Available at: https://doi.org/10.1093/cid/ciac714.

Welzel, Tatjana, Aeschlimann, Florence and Woerner, Andreas (2023) ‘Autoinflammatorische Erkrankungen’, Rheuma Schweiz, n.a.(03), pp. 62–68.

Piezzi V et al. (2022) ‘Focusing on the follow-up for detecting surgical site infections after total joint arthroplasty and cardiac surgery: A cohort study from the Swiss national surveillance system, 2009-2018’, 43(12). Available at: https://doi.org/10.1017/ice.2022.77.

Bielicki I, Subotic U and Bielicki JA (2022) ‘Systematic literature review on surgical site preparation in paediatric surgery’, BMC Pediatrics, 22(1), p. 455. Available at: https://doi.org/10.1186/s12887-022-03502-z.

Birrer M et al. (2022) ‘Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections’, Antimicrobial Resistance and Infection Control, 11(1), p. 2. Available at: https://doi.org/10.1186/s13756-021-01038-y.

Bräm DS et al. (2022) ‘Evaluation of machine learning methods for covariate data imputation in pharmacometrics’, CPT: Pharmacometrics and Systems Pharmacology, 11(12), pp. 1638–1648. Available at: https://doi.org/10.1002/psp4.12874.

Hassoun-Kheir N et al. (2022) ‘Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases’, Clinical Microbiology and Infection, 28(12), pp. 1528–1532. Available at: https://doi.org/10.1016/j.cmi.2022.07.024.

Kürner K et al. (2022) ‘Vaginal Delivery Is Associated with Neurochemical Evidence of Increased Neuroaxonal Remodelling in Infants from the KUNO-Kids Health Study: Cross-Sectional Analysis’, Neonatology, 119(6), pp. 769–776. Available at: https://doi.org/10.1159/000526472.

Piezzi V et al. (2022) ‘Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, Switzerland, 2017 to 2020’, Eurosurveillance, 27(48). Available at: https://doi.org/10.2807/1560-7917.ES.2022.27.48.2200285.

Salazar-Vizcaya L et al. (2022) ‘The impact of public health interventions on the future prevalence of ESBL-producing Klebsiella pneumoniae: a population based mathematical modelling study’, BMC Infectious Diseases, 22(1), p. 487. Available at: https://doi.org/10.1186/s12879-022-07441-z.

Schöning V et al. (2022) ‘Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern’, 20(1). Available at: https://doi.org/10.1186/s12967-022-03634-x.

Smits A et al. (2022) ‘Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper’, British Journal of Clinical Pharmacology, 88(12), pp. 4965–4984. Available at: https://doi.org/10.1111/bcp.14958.

Villabruna N et al. (2022) ‘Profiling of humoral immune responses to norovirus in children across Europe’, Scientific Reports, 12(1), p. 14275. Available at: https://doi.org/10.1038/s41598-022-18383-6.

Nyantakyi E et al. (2022) ‘Implementation of infection prevention and control for hospitalized neonates: A narrative review.’, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Preprint]. Available at: https://doi.org/10.1016/j.cmi.2022.11.007.

Surial B et al. (2022) ‘Better operating room ventilation as determined by a novel ventilation index is associated with lower rates of surgical site infections’, Annals of Surgery, 276(5), pp. E353–E360. Available at: https://doi.org/10.1097/SLA.0000000000005670.

Ziesenitz VC et al. (2022) ‘Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.’, Paediatric drugs, 24(6), pp. 603–655. Available at: https://doi.org/10.1007/s40272-022-00514-1.

Weber ANR et al. (2022) ‘Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3.’, Rheumatology (Oxford, England), 61(10), pp. e299–e313. Available at: https://doi.org/10.1093/rheumatology/keac273.

Bielicki J.A. and Manuel O. (2022) ‘Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland’, Transplant Infectious Disease, 24(5). Available at: https://doi.org/10.1111/tid.13902.

Kopsidas I et al. (2022) ‘Hand Hygiene Compliance Rates in 9 Pediatric Intensive Care Units Across Europe: Results from the Reducing Antimicrobial use and Nosocomial Infections in Kids Network’, Pediatric Infectious Disease Journal, 41(10), pp. E434–E437. Available at: https://doi.org/10.1097/INF.0000000000003658.

Sharland E et al. (2022) ‘Can the history of empiric antibiotic treatment for neonatal sepsis inform future global trials?’, Clinical Microbiology and Infection, 28(10), pp. 1313–1315. Available at: https://doi.org/10.1016/j.cmi.2022.06.006.

Paioni, Paolo et al. (2022) ‘Swiss recommendations on perioperative antimicrobial prophylaxis in children’, Swiss Medical Weekly, 152(3738). Available at: https://doi.org/10.4414/SMW.2022.w30230.

Hirzel C et al. (2022) ‘Infection Risk in the First Year after ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study’, Transplantation, 106(9), pp. 1875–1883. Available at: https://doi.org/10.1097/TP.0000000000004109.

Welzel T et al. (2022) ‘Tapering of biological treatment in autoinflammatory diseases: a scoping review.’, Pediatric rheumatology online journal, 20(1), p. 67. Available at: https://doi.org/10.1186/s12969-022-00725-3.

Mack I. et al. (2022) ‘Wearable Technologies for Pediatric Patients with Surgical Infections—More than Counting Steps?’, Biosensors, 12(8). Available at: https://doi.org/10.3390/bios12080634.

Welzel T et al. (2022) ‘Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review.’, Journal of clinical medicine, 11(15). Available at: https://doi.org/10.3390/jcm11154369.

Jent P et al. (2022) ‘Antibiotics for Preventing Recurrent Urinary Tract Infection: Systematic Review and Meta-analysis’, Open Forum Infectious Diseases, 9(7), p. ofac327. Available at: https://doi.org/10.1093/ofid/ofac327.

Tilen R et al. (2022) ‘Pharmacogenetic Analysis of Voriconazole Treatment in Children’, Pharmaceutics, 14(6). Available at: https://doi.org/10.3390/pharmaceutics14061289.

Gerull R et al. (2022) ‘Respiratory morbidity in preterm infants predicted by natriuretic peptide (MR-proANP) and endothelin-1 (CT-proET-1)’, Pediatric Research, 91(6), pp. 1478–1484. Available at: https://doi.org/10.1038/s41390-021-01493-8.

Verberk JDM et al. (2022) ‘Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries’, European Journal of Epidemiology, 37(5), pp. 549–561. Available at: https://doi.org/10.1007/s10654-022-00870-9.

Atkinson A et al. (2022) ‘A Bayesian spatiotemporal model for prevalence estimation of a VRE outbreak in a tertiary care hospital’, Journal of Hospital Infection, 122, pp. 108–114. Available at: https://doi.org/10.1016/j.jhin.2021.12.024.

Hachfeld A. et al. (2022) ‘Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)’, HIV Medicine, 23(4), pp. 417–425. Available at: https://doi.org/10.1111/hiv.13255.

Bielicki JA and Sharland M (2022) ‘Amoxicillin Dose and Duration of Treatment and Need for Antibiotic Re-treatment in Children with Community-Acquired Pneumonia - Reply’, 327(11). Available at: https://doi.org/10.1001/jama.2022.1046.

Wu YE et al. (2022) ‘Clinical utiliy of a model-based piperacillin dose in neonates with early-onset sepsis’, British Journal of Clinical Pharmacology, 88(3), pp. 1179–1188. Available at: https://doi.org/10.1111/bcp.15058.

Touw DJ and van den Anker JN (2022) ‘Therapeutic Drug Monitoring of Antimicrobial Drugs in Neonates: An Opinion Article’, Therapeutic Drug Monitoring, 44(1), pp. 65–74. Available at: https://doi.org/10.1097/FTD.0000000000000919.

Baumann, Philipp et al. (2022) ‘Copeptin Release in Arterial Hypotension and Its Association with Severity of Disease in Critically Ill Children’, Children, 9. Available at: https://doi.org/10.3390/children9060794.

Bruningk, Sarah C. et al. (2022) ‘Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area’, Virus Evolution, 8(1), p. veac002. Available at: https://doi.org/10.1093/ve/veac002.

Cook A et al. (2022) ‘Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)’, Expert Review of Anti-Infective Therapy, 20(3), pp. 445–456. Available at: https://doi.org/10.1080/14787210.2021.1967145.

Golhen K et al. (2022) ‘Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.’, Frontiers in medicine, 9, p. 944208. Available at: https://doi.org/10.3389/fmed.2022.944208.

Golhen K et al. (2022) ‘Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.’, 10. Available at: https://doi.org/10.3389/fped.2022.909118.

Hachfeld A et al. (2022) ‘Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)’, HIV Medicine, 23(1), pp. 60–69. Available at: https://doi.org/10.1111/hiv.13152.

Huber, Francois et al. (2022) ‘Rapid Bacteria Detection from Patients” Blood Bypassing Classical Bacterial Culturing’, Biosensors, 12(11), p. 994. Available at: https://doi.org/10.3390/bios12110994.

Levine, G., Bielicki, J. and Fink, G. (2022) ‘Cumulative antibiotic exposure in the first five years of life: estimates for 45 low- and middle-income countries from demographic and health survey data’, Clinical infectious diseases, 75(9), pp. 1537–1547. Available at: https://doi.org/10.1093/cid/ciac225.

Samiee-Zafarghandy S et al. (2022) ‘Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates’, Archives of Disease in Childhood, 107(1), pp. 86–91. Available at: https://doi.org/10.1136/archdischild-2020-321381.

Smit, C. et al. (2022) ‘Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure’, Antibiotics (Basel), 11(9), p. 1190. Available at: https://doi.org/10.3390/antibiotics11091190.

Welzel T et al. (2022) ‘Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland.’, Frontiers in pediatrics, 10, p. 993811. Available at: https://doi.org/10.3389/fped.2022.993811.

Welzel T et al. (2022) ‘Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.’, Frontiers in pediatrics, 10, p. 905046. Available at: https://doi.org/10.3389/fped.2022.905046.

Yang F et al. (2022) ‘Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia’, Clinical Pharmacokinetics, 61(1), pp. 71–81. Available at: https://doi.org/10.1007/s40262-021-01054-6.

Bielicki I, Subotic U and Bielicki JA (2022) ‘Systematic literature review on surgical site prevention in paediatric surgery’, BMC Pediatrics [Preprint].

Atkinson A et al. (2021) ‘Surveillance quality correlates with surgical site infection rates in knee and hip arthroplasty and colorectal surgeries: A call to action to adjust reporting of SSI rates’, Infection Control and Hospital Epidemiology, 42(12), pp. 1451–1457. Available at: https://doi.org/10.1017/ice.2021.14.

Sommerstein R et al. (2021) ‘Association between Antimicrobial Prophylaxis with Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More’, JAMA Network Open, 4(12), p. e2138926. Available at: https://doi.org/10.1001/jamanetworkopen.2021.38926.

Allegaert K, Ceulemans M and van den Anker J (2021) ‘Maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery’, 77(12). Available at: https://doi.org/10.1007/s00228-021-03191-0.

Buetti, Niccolò et al. (2021) ‘Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland’, Clinical Microbiology and Infection, 27(12), pp. 1820–1825. Available at: https://doi.org/10.1016/j.cmi.2021.04.025.

Goers R et al. (2021) ‘SwissPKcdw – A clinical data warehouse for the optimization of pediatric dosing regimens’, CPT: Pharmacometrics and Systems Pharmacology, 10(12), pp. 1578–1587. Available at: https://doi.org/10.1002/psp4.12723.

Schöning V et al. (2021) ‘Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital’, Journal of Translational Medicine, 19(1), p. 56. Available at: https://doi.org/10.1186/s12967-021-02720-w.

Welzel T et al. (2021) ‘Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants’, Pediatric Rheumatology, 19(1), p. 142. Available at: https://doi.org/10.1186/s12969-021-00588-0.

Yin HS et al. (2021) ‘Preventing Home Medication Administration Errors’, Pediatrics, 148(6). Available at: https://doi.org/10.1542/peds.2021-054666.

Welzel T et al. (2021) ‘Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis’, Frontiers in Pediatrics, 9, p. 759664. Available at: https://doi.org/10.3389/fped.2021.759664.

Bielicki JA et al. (2021) ‘Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children with Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial’, JAMA - Journal of the American Medical Association, 326(17), pp. 1713–1724. Available at: https://doi.org/10.1001/jama.2021.17843.

Donnelly KA et al. (2021) ‘Prescription Drug Shortages: Pediatric Emergency and Critical Care Medications’, Pediatric Emergency Care, 37(11), pp. E726–E731. Available at: https://doi.org/10.1097/PEC.0000000000001773.

Tang BH et al. (2021) ‘Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction’, Clinical Pharmacokinetics, 60(11), pp. 1435–1448. Available at: https://doi.org/10.1007/s40262-021-01033-x.

Liu X.I. et al. (2021) ‘Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?’, Frontiers in Pediatrics, 9. Available at: https://doi.org/10.3389/fped.2021.723006.

He CY et al. (2021) ‘Population pharmacokinetics and dosing optimization of vancomycin in infants, children, and adolescents with augmented renal clearance’, Antimicrobial Agents and Chemotherapy, 65(10), p. e0089721. Available at: https://doi.org/10.1128/AAC.00897-21.

Mian P et al. (2021) ‘Mechanistic Coupling of a Novel in silico Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery’, Frontiers in Pediatrics, 9, p. 733520. Available at: https://doi.org/10.3389/fped.2021.733520.

Guo ZX et al. (2021) ‘A simplified method for bortezomib determination using dried blood spots in combination with liquid chromatography/tandem mass spectrometry’, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1181, p. 122905. Available at: https://doi.org/10.1016/j.jchromb.2021.122905.

Haslund-Krog SS et al. (2021) ‘Challenges in conducting paediatric trials with off-patent drugs’, Contemporary Clinical Trials Communications, 23, p. 100783. Available at: https://doi.org/10.1016/j.conctc.2021.100783.

Li S et al. (2021) ‘Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery’, British Journal of Clinical Pharmacology, 87(9), pp. 3531–3541. Available at: https://doi.org/10.1111/bcp.14767.

van der Perk MEM et al. (2021) ‘Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study’, Cancers, 13(18). Available at: https://doi.org/10.3390/cancers13184598.

Zhao W, Wu YE and van den Anker J (2021) ‘Editorial: Model-Based Evaluation of Antimicrobial Agents in Children’, 12. Available at: https://doi.org/10.3389/fphar.2021.731209.

Gotta V et al. (2021) ‘Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age’, Pediatric Nephrology, 36(8), pp. 2421–2432. Available at: https://doi.org/10.1007/s00467-021-04972-6.

Liu XT et al. (2021) ‘Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia’, British Journal of Clinical Pharmacology, 87(8), pp. 3292–3300. Available at: https://doi.org/10.1111/bcp.14750.

Manz N et al. (2021) ‘Mis-c-implications for the pediatric surgeon: An algorithm for differential diagnostic considerations’, Children, 8(8). Available at: https://doi.org/10.3390/children8080712.